Abstract: Systems and methods for separation of hydrocarbon containing fluids are provided. More particularly, the disclosure is relevant to separating fluids having a gas phase, a hydrocarbon liquid phase, and an aqueous liquid phase using indirect heating. In general, the system uses a first gas separation followed by pressure reduction and then a second gas separation. Indirect follows the second gas separation and then three-phase separation.

Abstract: The present invention provides a composition comprising a phosphatidylinositol 3-kinase (PI3K) inhibitor and a modified virus for separate, subsequent or simultaneous use in the treatment of cancer, wherein the modified virus is for intravenous administration.

Abstract: A heat exchanger tube includes a central tube portion having a C-shape cross-section. A pair of tube ends includes the C-shape cross-section or a different cross-section. A heat exchanger tube assembly and a method for manufacturing a C-shape heat exchanger tube are also described.

Abstract: Systems and methods for separation of hydrocarbon containing fluids are provided. More particularly, the disclosure is relevant to separating fluids having a gas phase, a hydrocarbon liquid phase, and an aqueous liquid phase using indirect heating. In general, the system uses a first gas separation followed by pressure reduction and then a second gas separation. Indirect follows the second gas separation and then three-phase separation.

Abstract: Systems and methods for separation of hydrocarbon containing fluids are provided. More particularly, the disclosure is relevant to separating fluids having a gas phase, a hydrocarbon liquid phase, and an aqueous liquid phase using indirect heating. In general, the system uses a first gas separation followed by pressure reduction and then a second gas separation. Indirect follows the second gas separation and then three-phase separation.

Abstract: A heat exchanger tube includes a central tube portion having a C-shape cross-section. A pair of tube ends includes the C-shape cross-section or a different cross-section. A heat exchanger tube assembly and a method for manufacturing a C-shape heat exchanger tube are also described.

Abstract: Systems and methods for separation of hydrocarbon containing fluids are provided. More particularly, the disclosure is relevant to separating fluids having a gas phase, a hydrocarbon liquid phase, and an aqueous liquid phase using indirect heating. In general, the system uses a first gas separation followed by pressure reduction and then a second gas separation. Indirect follows the second gas separation and then three-phase separation.

Abstract: The present invention provides a composition comprising a phosphatidylinositol 3-kinase (PI3K) inhibitor and a modified virus for separate, subsequent or simultaneous use in the treatment of cancer, wherein the modified virus is for intravenous administration.

Abstract: A gantry style car wash assembly is disclosed. The car wash assembly has two opposing support pillars, a transverse gantry member, first and second opposed wall segments, and a brush mounted about a shaft. The transverse gantry member extends between the two opposing support pillars, and is moveable up and down relative to said two opposing support pillars. Each of the first and second opposed walls defines a portion of two opposing channels. The first and second removable wall segments are removably mountable above the first and second wall segments. Each wall segment includes a vertical extension channel that extends one of the two opposing channels substantially to said transverse gantry member. The brush extends between said first and second pillars, and that is mounted within said two opposing channels for upward and downward movement of said brush.

Abstract: A gantry style car wash assembly is disclosed. The car wash assembly has two opposing support pillars, a transverse gantry member, first and second opposed wall segments, and a brush mounted about a shaft. The transverse gantry member extends between the two opposing support pillars, and is moveable up and down relative to said two opposing support pillars. Each of the first and second opposed walls defines a portion of two opposing channels. The first and second removable wall segments are removably mountable above the first and second wall segments. Each wall segment includes a vertical extension channel that extends a one of the two opposing channels substantially to said transverse gantry member. The brush extends between said first and second pillars, and that is mounted within said two opposing channels for upward and downward movement of said brush.

Abstract: A holder for a portable item example mobile phone, comprising an attachment device and a holding device linked by a resilient member. The holder comprises non-slip material and is shaped to securely retain the portable item in the holder whilst allowing the item to remain operable.

Abstract: The invention provides pharmaceutical compositions comprising TGF-? superfamily members and sugars, the compositions allowing improved recovery and/or increased biological activity of the TGF-? superfamily member incorporated therein. The invention also relates to uses of sugars to improve the recovery or increase the biological activity of TGF-? superfamily members in a pharmaceutical composition. Uses of the pharmaceutical compositions are also described, particularly with reference to wound healing and fibrosis. Furthermore, the invention discloses medicaments for the prevention or reduction of injection pain.

Abstract: The invention relates to the use of TGF-?3, or agents having TGF-?3 activity, to promote epithelial regeneration. Methods of manufacturing medicaments, and methods of promoting epithelial regeneration are both provided. In particular, the medicaments and methods of treatment of the invention are applicable to the promotion of epithelial regeneration in healthy patients, and/or in acute wounds.

Abstract: The invention provides pharmaceutical compositions comprising TGF-? superfamily members and sugars, the compositions allowing improved recovery and/or increased biological activity of the TGF-? superfamily member incorporated therein. The invention also relates to uses of sugars to improve the recovery or increase the biological activity of TGF-? superfamily members in a pharmaceutical composition. Uses of the pharmaceutical compositions are also described, particularly with reference to wound healing and fibrosis. Furthermore, the invention discloses medicaments for the prevention or reduction of injection pain.

Abstract: The present invention relates to the manufacture of medicaments. In particular, the invention relates to the manufacture of medicaments for accelerating the healing of wounds. The invention also relates to methods of treatment for accelerating the healing of wounds. In particular the invention relates to medicaments and methods for the acceleration of healing of skin wounds.

Abstract: The present invention relates to medicaments and methods for promoting wound contraction. In certain embodiments the invention provides medicaments and methods capable of promoting wound contraction without acceleration of re-epithelialisation.

Abstract: The present invention relates to the manufacture of medicaments for accelerating the healing of wounds. The invention also relates to methods of treatment for accelerating the healing of wounds. In particular the invention relates to medicaments and methods for the acceleration of healing of skin wounds. The invention relates to wound dressings that are able to provide active agents to a wound, and thereby accelerate healing of the wound, and to formulations such as creams or sprays that may be used to accelerate healing.

Abstract: The present invention provides compositions and methods for promoting the healing of wounds or fibrotic disorders with reduced scarring, comprising inhibitors and inhibiting IFN-?, together with compositions and methods for promoting the healing of chronic wounds, comprising stimulating and stimulators of IFN-?.

Abstract: A method of equalization of fluid flow having a more balanced flow rate and spray pattern along a length of a fluid distribution arm comprising a plurality of apertures, the method comprising: partitioning a portion of an interior of the distribution arm into a first compartment and a second compartment, wherein the first compartment does not include any of the apertures; and passing fluid into the first compartment before entering the second compartment.

Abstract: The present application relates to the use of compounds that influence the sex hormone system for the treatment of wounds and/or fibrotic disorders. Preferred compounds for use in such treatments are steroid hormones and especially the oestrogens.